FREDRIC NEUMANN: Open Payments
NPI 1013009901 · STERLING HEIGHTS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,450 in 63 payments from 18 companies in 2025. Trend: 2023 $1,366 · 2024 $879 · 2025 $1,450
Food & beverage: $1,450
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 8 | $354 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 21 | $278 |
| Indivior Inc. | 4 | $132 |
| Corcept Therapeutics | 4 | $109 |
| Exact Sciences Corporation | 3 | $102 |
| Axsome Therapeutics, Inc. | 4 | $72 |
| PFIZER INC. | 2 | $59 |
| Otsuka America Pharmaceutical, Inc. | 3 | $57 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 3 | $47 |
Products named: CAPLYTA, VRAYLAR, SUBLOCADE, QULIPTA, Korlym, Cologuard Collection Kit, REXULTI, Kerendia.
Industry payments across MI — which companies pay providers there.
